J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dixon, J. L.
Right arrow Articles by Sturek, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dixon, J. L.
Right arrow Articles by Sturek, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 43, 1618-1629, October 2002
Copyright © 2002 by Lipid Research, Inc.

Increased atherosclerosis in diabetic dyslipidemic swine

: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile

Joseph L. Dixon1,*,**, Siming Shen{dagger}, James P. Vuchetich**, Elzbieta Wysocka*, Grace Y. Sun{dagger},** and Michael Sturek*,§,**

* Dalton Cardiovascular Research Center, University of Missouri, Research Park, Columbia, MO
{dagger} Department of Biochemistry, University of Missouri, Research Park, Columbia, MO
§ Departments of Physiology and Internal Medicine, School of Medicine, University of Missouri, Research Park, Columbia, MO
** Diabetes & Cardiovascular Biology Program, University of Missouri, Research Park, Columbia, MO

1 To whom correspondence should be addressed. e-mail: dixonj{at}missouri.edu

Male Yucatan swine were allocated to four groups (n = 5–6 pigs per group): low fat (3%) fed control, high fat/2% cholesterol (CH) fed (HF), high fat/CH fed with alloxan-induced diabetes (DF) and DF pigs that were treated with atorvastatin (80 mg/day; DF+A). Pigs were fed two meals per day and daily insulin injections were used in diabetic pigs to maintain plasma glucose between 250 and 350 mg/dl. Diabetic dyslipidemic (DF) pigs exhibited greater coronary atherosclerosis and increased collagen deposition in internal mammary artery compared with normoglycemic hyperlipidemic pigs. Although total and LDL CH concentrations did not differ, triglyceride (TG) were increased in DF pigs and FPLC analysis indicated that the LDL/HDL CH ratio was significantly increased in DF compared with HF pigs. The LDL fraction of DF pigs contained larger, lipid enriched particles resembling IDL. Consumption of the high fat/CH diet caused a moderate increase in the percentage of 14:0 fatty acids in plasma lipids and this was compensated by small-moderate declines in several unsaturated fatty acids. There was a significant increase in phospholipid arachidonic acid in DF compared with HF pigs. Atorvastatin protected diabetic pigs from atherosclerosis and decreased total and VLDL TG, but exerted minimal effects on the FPLC lipoprotein and plasma fatty acid profiles and plasma concentrations of total and LDL CH, vitamin A, vitamin E, and lysophosphatidylcholine. Across all groups the plasma CH concentration was positively correlated with hepatic CH concentration.

These findings suggest that atorvastatin's protection against coronary artery atherosclerosis in diabetes may involve effects on plasma VLDL TG concentration. Lack of major effects on other lipid parameters, including the LDL/HDL ratio, suggests that atorvastatin may have yet other anti-atherogenic effects, possibly directly in the vessel wall.

Abbreviations: CAD, coronary artery disease; CE, cholesteryl esters; CFX, circumflex; CH, cholesterol; DF, high fat/CH fed pigs with alloxan-induced diabetes; DF+A, high fat/CH fed pigs with alloxan-induced diabetes treated with atorvastatin; GC, gas chromatograph; HF or F, high fat/2% cholesterol fed pigs; HPTLC, high performance thin layer chromatography; LAD, left anterior descending; LPC, lysophosphatidylcholine; PC, phosphatidylcholine; PL, phospholipids; TG, triglyceride

Supplementary key words Yucatan miniature swine • LDL • HDL • remnants • cholesterol • triglycerides • hypertriglyceridemia • endothelium • vascular smooth muscle • coronary artery • statin • vitamin E • arachidonic acid


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
J. Zhou, G. H. Werstuck, S. Lhotak, Y. Y. Shi, V. Tedesco, B. Trigatti, J. Dickhout, A. K. Majors, P. M. DiBello, D. W. Jacobsen, et al.
Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice
FASEB J, July 1, 2008; 22(7): 2569 - 2578.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. N. Ginsberg
REVIEW: Efficacy and Mechanisms of Action of Statins in the Treatment of Diabetic Dyslipidemia
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 383 - 392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. A. Mokelke, N. J. Dietz, D. M. Eckman, M. T. Nelson, and M. Sturek
Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K+ current
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1233 - H1241.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. S. Korte, E. A. Mokelke, M. Sturek, and K. S. McDonald
Exercise improves impaired ventricular function and alterations of cardiac myofibrillar proteins in diabetic dyslipidemic pigs
J Appl Physiol, February 1, 2005; 98(2): 461 - 467.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Castro Cabezas, C. Verseyden, S. Meijssen, H. Jansen, and D. W. Erkelens
Effects of Atorvastatin on the Clearance of Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5972 - 5980.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Lee, B. R. Wamhoff, L. C. Katwa, H. K. Reddy, D. J. Voelker, J. L. Dixon, and M. Sturek
Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 132 - 140.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.